Argenta Discovery 2009 Limited
Records under this name other than patents Argenta Discovery 2009 Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Argenta Discovery 2009 Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,216,980 | Methods of Use of Diazacarbazoles for Treating Cancer conveyed to Genentech, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 8,501,765 | Diazacarbazoles and Methods of Use conveyed to Genentech, Inc. In force · High confidence | In force | High confidence | |
| US 8,242,104 | Benzoxazepin PI3K Inhibitor Compounds and Methods of Use conveyed to Genentech Inc. - now held by F. Hoffmann-La Roche AG In force · High confidence | In force | High confidence | |
| US 8,263,633 | Benzoxepin PI3K Inhibitor Compounds and Methods of Use conveyed to Genentech Inc. - now held by F. Hoffmann-La Roche AG In force · High confidence | In force | High confidence | |
| US 9,090,628 | Benzoxazepin Compounds Selective for PI3K P110 Delta and Methods of Use now held by F. Hoffmann-La Roche AG In force · High confidence | In force | High confidence | |
| US 9,120,802 | Pyrimidine Derivatives and Their Use in the Treatment of Respiratory Diseases Such as Copd conveyed to Pulmagen Therapeutics Inflammation Limited - now held by Chiesi Farmaceutici S.P.A. In force · Medium confidence | In force | Medium confidence | |
| US 9,156,844 | Pyrimidine Derivatives and Their Use in the Treatment of Respiratory Diseases Such as Copd conveyed to Pulmagen Therapeutics Inflammation Limited - now held by Chiesi Farmaceutici S.P.A. In force · Medium confidence | In force | Medium confidence | |
| US 8,883,799 | Tricyclic PI3K Inhibitor Compounds and Methods of Use conveyed to Genentech Inc. - now held by Kazia Therapeutics Limited In force · High confidence | In force | High confidence | |
| US 9,365,577 | Pyrimidinone Compounds as Human Neutrophil Elastase Inhibitors conveyed to Pulmagen Therapeutics Inflammation Limited - now held by Chiesi Farmaceutici S.P.A. In force · High confidence | In force | High confidence | |
| US 9,868,740 | Pyrimidinone Compounds Which Are Hne Inhibitors now held by Chiesi Farmaceutici S.P.A. In force · High confidence | In force | High confidence |